Synthetic resveratrol-curcumin hybrid derivative inhibits mitosis progression in estrogen positive MCF-7 breast cancer cells.

de Freitas Silva, Matheus

Synthetic resveratrol-curcumin hybrid derivative inhibits mitosis progression in estrogen positive MCF-7 breast cancer cells. [electronic resource] - Toxicology in vitro : an international journal published in association with BIBRA Aug 2018 - 75-85 p. digital

Publication Type: Journal Article

1879-3177

10.1016/j.tiv.2018.02.020 doi


A549 Cells
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Aurora Kinase A--genetics
Breast Neoplasms--metabolism
Cell Cycle Proteins--genetics
Cell Line
Cell Survival
Curcumin--pharmacology
Cyclin B1--genetics
Cyclin-Dependent Kinase Inhibitor p21--genetics
Drug Combinations
Estrogens--metabolism
Gene Expression Regulation, Neoplastic--drug effects
Hep G2 Cells
Humans
MCF-7 Cells
Mitosis--drug effects
Protein Serine-Threonine Kinases--genetics
Proto-Oncogene Proteins--genetics
Resveratrol
Stilbenes--pharmacology
Polo-Like Kinase 1